Enthesis healing
US-2024390292-A1 · Nov 28, 2024 · US
US9345867B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9345867-B2 |
| Application number | US-201514882458-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 14, 2015 |
| Priority date | Mar 27, 2003 |
| Publication date | May 24, 2016 |
| Grant date | May 24, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A device implantable in tissue of a prostate gland or a bladder is described. The device includes a device body, a retrieval portion, a medicament, and a medicament carrier. The device body includes a first end and a second end opposite of the first end. The first end has a sharp tip adapted for penetrating the tissue. The retrieval portion connected to the second end of the device body. The medicament is applied to the device to therapeutically treat the prostate gland or the bladder. The carrier is a hydrogel, a silicone based material, an elastomer, a proteinaceous material, a polyethylene glycol material, a carbohydrate material, or a polysaccharide carbohydrate material that provides controlled delivery of the medicament over a duration of time.
Opening claim text (preview).
What is claimed is: 1. A device implantable in tissue of one of a prostate gland and a bladder, the device comprising: a device body including a first end and a second end opposite of the first end, the first end having a sharp tip adapted for penetrating the tissue and the second end of the device body provides a head of the device; a retrieval portion connected to the second end of the device body; a medicament applied to the head of the device to therapeutically treat the one of the prostate gland and the bladder; and a carrier applied to the device; wherein the carrier is one of a hydrogel, a silicone based material, an elastomer, a proteinaceous material, a polyethylene glycol material, a carbohydrate material, and a polysaccharide carbohydrate material that provides controlled delivery of the medicament over a duration of time. 2. The device of claim 1 , wherein the device body is absorbable. 3. The device of claim 1 , wherein the device body is formed to provide a spiral shape. 4. The device of claim 1 , wherein the device body is formed to provide a J-shape. 5. The device of claim 1 , wherein the device body is formed to provide a U-shape. 6. The device of claim 1 , wherein the device body is a mesh. 7. The device of claim 1 , wherein the device body is cylindrical mesh. 8. The device of claim 1 , wherein the head of the device has a diameter that is larger than a diameter of the first end of the device. 9. The device of claim 1 , wherein the retrieval portion is a one of a length of a cord, a twine, a fiber, and a string.
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics · CPC title
Proteins; Polypeptides; Degradation products thereof · CPC title
Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception · CPC title
obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds {(A61L31/041 takes precedence)} · CPC title
bioabsorbable · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.